Association of TNF-α and TNFR1 promoters and 3′ UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians

Oral Oncology

Volumn 44, Issue 5, 2008, Pages 455-463

  Gupta, Reeshu ^a   Sharma, Suresh C ^a   Das, Satya N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Asian Indians; Oral squamous cell carcinoma; Single nucleotide polymorphism (SNP); Tumor necrosis factor (TNF)

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ARTICLE; ASIAN; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SQUAMOUS CELL CARCINOMA; TOBACCO;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TOBACCO, SMOKELESS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 42749084993     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2007.06.003     Document Type: Article

References (37)

1. Indian Cancer Registry. Indian Council of Medical Research; 1992.
2. See D., Mason S., and Roshan R. Increased tumor necrosis factor alpha (TNF-alpha) and natural killer cell (NK) function using an integrative approach in late stage cancers. Immunol Invest 31 (2002) 137-153
3. Frater-Schroder M., Risau W., Hallmann R., Gautschi P., and Bohlen P. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 84 (1987) 5277-5281
4. Naylor M.S., Stamp G.W., Foulkes W.D., Eccles D., and Balkwill F.R. Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J Clin Invest 91 (1993) 2194-2206
5. Oppenheim J.J., and Feldmann M. Cytokine reference: a compendium of cytokine and other mediators of host defense. In: Aggarwal B.B., Samata A., and Feldmann M. (Eds). TNF receptors (2001), Academic Press, London 1619-1632
6. Su T.R., Chang K.L., Lee C.H., Chen C.H., Yang Y.H., and Shieh T.Y. Expression of tumor necrosis factor-alpha and its soluble receptors in betel-quid-chewing patients at different stages of treatment for oral squamous cell carcinoma. Oral Oncol 40 (2004) 804-810
7. Arnott C.H., Scott K.A., Moore R.J., Robinson S.C., Thomson R.G., and Balkwill F.R. Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development. Oncogene 23 (2004) 1902-1910
8. Starcher B. Role for tumour necrosis factor-alpha receptors in ultraviolet-induced skin tumours. Br J Dermatol 142 (2000) 1140-1147
9. Pitts S.A., Olomolaiye O.O., Elson C.J., Westacott C.I., and Bidwell J.L. Identification of a rare Bg/II polymorphism in the promoter region of the human TNF receptor type I (p55) gene. Eur J Immunogenet 25 (1998) 271-272
10. Pantelidis P., Lympany P.A., Foley P.J., Fanning G.C., Welsh K.I., and du Bois R.M. Polymorphic analysis of the high-affinity tumor necrosis factor receptor 2. Tissue Antigens 54 (1999) 585-591
11. Bazzoni F., Gatto L., Lenzi L., Vinante F., Pizzolo G., Zanolin E., et al. Identification of novel polymorphisms in the human TNFR1 gene: distribution in acute leukemia patients and healthy individuals. Immunogenetics 5 (2000) 159-163
12. Marsh H.P., Haldar N.A., Bunce M., Marshall S.E., le Monier K., Winsey S.L., et al. Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation. Br J Cancer 89 (2003) 1096-1101
13. Nonomura N., Tokizane T., Nakayama M., Inoue H., Nishimura K., Muramatsu M., et al. Possible correlation between polymorphism in the tumor necrosis factor-beta gene and the clinicopathological features of bladder cancer in Japanese patients. Int J Urol 13 (2006) 971-976
14. Jeong P., Kim E.J., Kim E.G., Byun S.S., Kim C.S., and Kim W.J. Association of bladder tumors and GA genotype of -308 nucleotide in tumor necrosis factor-alpha promoter with greater tumor necrosis factor-alpha expression. Urology 64 (2004) 1052-1056
15. Nakajima K., Sasaki M., Nojima D., Oh B.R., Ishii N., Miura K., et al. Tumor necrosis factor-alpha gene mutations and genotype changes in renal cell carcinoma. J Urol 165 (2001) 612-615
16. Shih C.M., Lee Y.L., Chiou H.L., Chen W., Chang G.C., Chou M.C., et al. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer 52 (2006) 15-20
17. Govan V.A., Constant D., Hoffman M., and Williamson A.L. The allelic distribution of -308 tumor necrosis factor-alpha gene polymorphism in South African women with cervical cancer and control women. BMC Cancer 6 (2006) 24
18. Mestiri S., Bouaouina N., Ahmed S.B., Khedhaier A., Jrad B.B., Remadi S., et al. Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. Cancer 91 (2001) 672-678
19. Das S.N., Baniasadi V., and Kapuria V. Association of -308 TNF-alpha promoter polymorphism with type 1 diabetes in North Indians. Int J Immunogenet 33 (2006) 411-416
20. Jang W.H., Yang Y.I., Yea S.S., Lee Y.J., Chun J.H., Kim H.I., et al. The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 166 (2001) 41-46
21. Allen R.A., Lee E.M., Roberts D.H., Park B.K., and Pirmohamed M. Polymorphisms in the TNF-alpha and TNF-receptor genes in patients with coronary artery disease. Eur J Clin Invest 31 (2001) 843-851
22. Santee S.M., and Owen-Schaub L.B. Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization. J Biol Chem 271 (1996) 21151-21159
23. Mittal K.K. HLA polymorphism and susceptibility to disease. Vox Sang 31 (1976) 161-173
24. Ferrajoli A., Keating M.J., Manshouri T., et al. The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia. Blood 100 (2002) 1215-1219
25. Michalaki V., Syrigos K., Charles P., and Waxman J. Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer 90 (2004) 2312-2316
26. Kroeger K.M., Carville K.S., and Abraham L.J. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34 (1997) 391-399
27. Wilson A.G., di Giovine F.S., Blakemore A.I., and Duff G.W. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1 (1992) 353
28. Higuchi T., Seki N., Kamizono S., Yamada A., Kimura A., Kato H., et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 51 (1998) 605-612
29. Hajeer A.H., and Hutchinson I.V. TNF-alpha gene polymorphism: clinical and biological implications. Microsc Res Tech 50 (2000) 216-228
30. Ho S.Y., Wang Y.J., Chen H.L., et al. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene. Cancer Causes Control 15 (2004) 657-663
31. Machado J.C., Figueiredo C., Canedo P., Pharoah P., Carvalho R., Nabais S., et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 125 (2003) 364-371
32. Wu H.C., Chang C.H., Chen H.Y., Tsai F.J., Tsai J.J., and Chen W.C. p53 gene codon 72 polymorphism but not tumor necrosis factor-alpha gene is associated with prostate cancer. Urol Int 73 (2004) 41-46
33. Baseggio L., Bartholin L., Chantome A., Charlot C., Rimokh R., and Salles G. Allele-specific binding to the -308 single nucleotide polymorphism site in the tumour necrosis factor-alpha promoter. Eur J Immunogenet 31 (2004) 15-19
34. Tartaglia L.A., Pennica D., and Goeddel D.V. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 268 (1993) 18542-18558
35. Peschon J.J., Torrance D.S., Stocking K.L., Glaccum M.B., Otten C., Willis C.R., et al. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 160 (1998) 943-952
36. Knight B., Yeoh G.C., Husk K.L., Ly T., Abraham L.J., Yu C., et al. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med 192 (2000) 1809-1818
37. Bayley J.P., Bakker A.M., Kaijzel E.L., Huizinga T.W., and Verweij C.L. Association of polymorphisms of the tumour necrosis factor receptors I and II and rheumatoid arthritis. Rheumatol (Oxford) 42 (2003) 969-971